Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,735 public trials 587 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Completed

Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib

NCT04526704

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +9 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

A Study of Nivolumab in Selected Uterine Cancer Patients

NCT03241745

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +25 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03150810

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • Start Midwest Grand Rapids, Michigan, United States
  • Washington University in St Louis St Louis, Missouri, United States
  • Mount Sinai Prime New York, United States
  • Montefiore Medical Park At Eastchester Einstein Campus The Bronx, New York, United States
View all 22 locations
View Trial Details

Related conditions